Caricamento...
2172. Assessment of Cefepime Neurotoxicity in the FDA Adverse Reporting System
BACKGROUND: Cefepime is a fourth-generation cephalosporin antibiotic used for the treatment of neutropenic fever, pneumonia, and urinary tract infections. The safety of cefepime is now being questioned as it has recently been implicated as a possible cause for lesser known adverse effects, including...
Salvato in:
| Pubblicato in: | Open Forum Infect Dis |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6254527/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.1828 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|